메뉴 건너뛰기




Volumn 68, Issue 3, 2008, Pages 343-349

Home administration of lanreotide Autogel® by patients with acromegaly, or their partners, is safe and effective

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; GROWTH HORMONE; LANREOTIDE AUTOGEL; LANTREOTIDE AUTOGEL; SOMATOMEDIN C; UNCLASSIFIED DRUG;

EID: 39149094648     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03044.x     Document Type: Article
Times cited : (52)

References (8)
  • 1
  • 3
    • 1542515274 scopus 로고    scopus 로고
    • Lanreotide Autogel for acromegaly: A new addition to the treatment armamentarium
    • Ciccarelli, A., Daly, A. Beckers, A. (2004) Lanreotide Autogel for acromegaly: a new addition to the treatment armamentarium. Treatments in Endocrinology, 3, 77 81.
    • (2004) Treatments in Endocrinology , vol.3 , pp. 77-81
    • Ciccarelli, A.1    Daly, A.2    Beckers, A.3
  • 8
    • 33645025605 scopus 로고    scopus 로고
    • Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly
    • Caron, P., Cogne, M., Raingeard, I., Bex-Bachellerie, V. Kuhn, J.M. (2006) Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly. Clinical Endocrinology, 64, 209 214.
    • (2006) Clinical Endocrinology , vol.64 , pp. 209-214
    • Caron, P.1    Cogne, M.2    Raingeard, I.3    Bex-Bachellerie, V.4    Kuhn, J.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.